Sign in

CIK 0001851484 · <br>Emerging growth company

CITIUS ONCOLOGY, INC.

Sign in to watch
Ticker
CTOR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
994362660
Phone
(908) 967-6677
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
TenX Keane Acquisition
  1. 4 Grant or award Chief Medical Officer acquired 825,000 shares (grant or award)
  2. 4 Grant or award Director acquired 300,000 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 825,000 shares (grant or award)
  4. 4 Grant or award Director acquired 300,000 shares (grant or award)
  5. 4 Grant or award Director acquired 300,000 shares (grant or award)
  6. 4 Grant or award Director acquired 300,000 shares (grant or award)
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 8-K Event Unregistered share sale · Executive or director change
  9. SCHEDULE 13D/A Stake Beneficial Ownership Report
  10. 424B3 Offering Prospectus
  11. 8-K Event Material agreement · Unregistered share sale · Other events
  12. 424B5 Offering Prospectus
  13. EFFECT Other Notice of Effectiveness
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. S-3 Offering Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. DRS Other Draft Registration Statement
  18. 8-K Event Other events
  19. 424B3 Offering Prospectus
  20. 8-K Event Results of operations

Page 5 of 14 · 268 filings